Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for left ventricular hypertrophy in normotensive patients with coronary artery disease
2014-003189-26Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and insulin resistance (IR) comparing Metformin extended-release with Placebo (2 arms). Primary endpoint: Change in left ventricular mass index. Started Oct 2014; status: completed.
02
Drugs
metformin
03
Conditions
coronary arteriosclerosisinsulin resistance (IR)
Beyond the preview
Go deeper on 2014-003189-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003189-26.